Icon

SYMBICORT (nda021929)- (0.08MG/INH;0.0045MG/INH,0.16MG/INH;0.0045MG/INH)

BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE ASTRAZENECA
0.08MG/INH;0.0045MG/INH,0.16MG/INH;0.0045MG/INH
Yes No
2029-Oct-07 Expired
None None
None No
SYMBICORT is a combination product containing a corticosteroid and a long-acting beta2-adrenergic agonist indicated for: • Treatment of asthma in patients 6 years of age and older. • Maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD) including chronic bronchitis and/or emphysema.
1 0 1
Total Other Developers 10
Drugs with Suitability No
0.08MG/INH;0.0045MG/INH ** ** Up - 1
0.16MG/INH;0.0045MG/INH ** ** Up 1 -
NDA Sales Available Total Generic Sales Available
Yes 1
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** ******* **** ******** *.*. *********** ***** ******** ******, **********, ********** (**) *****-****, ****** ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.